COGT logo

Cogent Biosciences, Inc. (COGT)

Profile

Full Name

Cogent Biosciences, Inc.

Ticker

NASDAQ: COGT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 29, 2018

Indexes

Not included

Website

http://www.cogentbio.com

Employees

205

Key Details

Price

$12.19(-1.46%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.94(0.00% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.19
    COGT price is $12.19

    30-Day Relative Volume

    0.48
    COGT 30-day relative volume is 0.48

    Price Performance

    Price Most recent change

    -1.46%
    COGT price was down -1.46% on Jul 24, 2025

    Price YTD change

    +56.28%
    COGT price is up +56.28% since January 1st

    Price 1-year change

    +32.21%
    COGT price is up +32.21% year-on-year

    Price 3-year change

    +8.45%
    COGT price is up +8.45% over the past 3 years

    Price Range

    Price All-time high

    $70.64
    COGT price is currently -82.74% below its historical high of $70.64

    Price 3-year low

    $3.67
    COGT price is currently +232.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.70B
    COGT market capitalization is $1.70 billion

    Market cap 3-year change

    +130.1%
    COGT market capitalization is up +130.1% over the past 3 years

    Market cap All-time high

    $1.74B
    COGT market capitalization is currently -2.40% below its historical high of $1.74 billion

    Market cap sector rank

    80.3%
    COGT market capitalization is higher than 80.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +27.5%
    COGT shares outstanding is up +27.5% year-on-year

    Shares Outstanding 3-Year Change

    +112.17%
    COGT shares outstanding is up +112.17% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.44
    COGT beta is 1.44

    200-day SMA

    $8.01
    COGT price is currently +52.19% above its 200-day simple moving average

    50-day SMA

    $7.72
    COGT price is currently +58.00% above its 50-day simple moving average

    RSI

    81.42
    COGT 14-day relative strength index is 81.42

    Volume

    0.48
    COGT 30-day relative volume is 0.48

    ATR

    $0.67
    COGT average true range is $0.67

    10-day Historical Volatility

    29.96%
    COGT 10-day historical volatility is 29.96%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    COGT annual revenue value is unknown

    Revenue Analysts estimate

    -
    COGT annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    COGT annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    COGT annual revenue is unknown

    EPS

    EPS

    -$1.94
    COGT annual earnings per share is -$1.94

    EPS Analysts estimate

    -$2.14
    COGT annual earnings per share is currently -9.54% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    COGT annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    39.62%
    COGT annual earnings per share is higher than 39.62% of companies in Healthcare sector

    Profit

    Gross profit

    -
    COGT annual gross profit value is unknown

    Gross margin

    -
    COGT annual gross profit margin value is unknown

    Operating profit

    -$275.94M
    COGT annual operating income is -$275.94 million

    Operating margin

    -
    COGT annual operating profit margin value is unknown

    Net income

    -$255.86M
    COGT annual net profit is -$255.86 million

    Net margin

    -
    COGT annual net profit margin value is unknown

    Expenses

    Total expenses

    $275.94M
    COGT annual total expenses is $275.94 million

    Operating expenses

    $275.94M
    COGT annual total operating expenses is $275.94 million

    Cost of goods sold

    -
    COGT annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $43.28M
    COGT annual SGA is $43.28 million

    Depreciation and amortization

    $4.35M
    COGT annual depreciation & amortization is $4.35 million

    Interest expense

    -
    COGT annual interest expense value is unknown

    Income tax

    -
    COGT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$275.94M
    COGT annual earnings before interest & taxes is -$275.94 million

    EBITDA

    -$271.59M
    COGT annual EBITDA is -$271.59 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $327.90M
    COGT annual total assets is $327.90 million

    Non current assets

    $31.43M
    COGT annual long term assets is $31.43 million

    Current assets

    $296.47M
    COGT annual total current assets is $296.47 million

    Cash and cash equivalents

    $98.17M
    COGT annual cash & cash equivalents is $98.17 million

    Accounts receivable

    -
    COGT annual accounts receivable value is unknown

    Inventory

    -
    COGT annual inventory value is unknown

    Liabilities

    Total liabilities

    $71.61M
    COGT annual total liabilities is $71.61 million

    Long term liabilities

    $15.90M
    COGT annual total long term liabilities is $15.90 million

    Current liabilities

    $55.71M
    COGT annual total current liabilities is $55.71 million

    Accounts payable

    $12.01M
    COGT annual accounts payable is $12.01 million

    Debt

    Total debt

    $17.47M
    COGT annual total debt is $17.47 million

    Total debt 1-year change

    -7.35%
    COGT annual total debt is down -7.35% year-on-year

    Long term debt

    $15.90M
    COGT annual long term debt is $15.90 million

    Short term debt

    $1.56M
    COGT annual short term debt is $1.56 million

    Equity & Capital

    Shareholders equity

    $256.29M
    COGT annual stockholders equity is $256.29 million

    Book value

    $145.69M
    COGT annual book value is $145.69 million

    Retained earnings

    -$859.48M
    COGT annual retained earnings is -$859.48 million

    Working capital

    $240.76M
    COGT annual working capital is $240.76 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$207.79M
    COGT annual cash flow from operations is -$207.79 million

    Cash from operations 1-year change

    -35.26%
    COGT annual cash flow from operations is down -35.26% year-on-year

    Cash from investing

    $38.28M
    COGT annual cash flow from investing activities is $38.28 million

    Cash from investing 1-year change

    +139.13%
    COGT annual cash flow from investing activities is up +139.13% year-on-year

    Cash from financing

    $214.45M
    COGT annual cash flow from financing activities is $214.45 million

    Cash from financing 1-year change

    +31.13%
    COGT annual cash flow from financing activities is up +31.13% year-on-year

    CAPEX

    CAPEX

    -
    COGT annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    COGT annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$208.36M
    COGT annual free cash flow is -$208.36 million

    Free cash flow 1-year change

    -33.21%
    COGT annual free cash flow is down -33.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    COGT annual gross profit margin value is unknown

    Operating margin

    -
    COGT annual operating profit margin value is unknown

    Net margin

    -
    COGT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -78.03%
    COGT annual return on assets is -78.03%

    ROE

    -99.83%
    COGT annual return on equity is -99.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    COGT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    COGT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    15.33
    COGT price to book ratio is 15.33

    PB ratio Sector rank

    92.98%
    COGT price to book ratio is higher than 92.98% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    COGT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    COGT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.59B
    COGT enterprise value is $1.59 billion

    Enterprise value Sector rank

    78.42%
    COGT enterprise value is higher than 78.42% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.60
    COGT EV/EBITDA is -5.60

    EV/EBITDA Sector rank

    23.22%
    COGT EV/EBITDA is higher than 23.22% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.32
    COGT annual current ratio is 5.32

    Quick ratio

    -
    COGT annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.07
    COGT annual debt to equity ratio is 0.07

    Interest coverage ratio

    -
    COGT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    COGT piotroski f-score value is unknown

    Altman Z-Score

    -
    COGT altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 18, 25 Citigroup
    Buy
    Jul 10, 25 JP Morgan
    Overweight
    Jul 8, 25 HC Wainwright & Co.
    Buy
    Jul 8, 25 Guggenheim
    Buy
    Jul 8, 25 Baird
    Neutral
    Jul 7, 25 Leerink Partners
    Outperform
    Jul 7, 25 Jefferies
    Buy
    Jun 17, 25 Needham
    Hold
    May 29, 25 JP Morgan
    Overweight
    May 20, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with COGT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Cogent Biosciences, Inc.?
    • Does Cogent Biosciences, Inc. pay dividends?
    • What sector is Cogent Biosciences, Inc. in?
    • What industry is Cogent Biosciences, Inc. in?
    • What country is Cogent Biosciences, Inc. based in?
    • When did Cogent Biosciences, Inc. go public?
    • Is Cogent Biosciences, Inc. in the S&P 500?
    • Is Cogent Biosciences, Inc. in the NASDAQ 100?
    • Is Cogent Biosciences, Inc. in the Dow Jones?
    • When was Cogent Biosciences, Inc.'s last earnings report?
    • When does Cogent Biosciences, Inc. report earnings?

    What is the ticker symbol for Cogent Biosciences, Inc.?

    The ticker symbol for Cogent Biosciences, Inc. is NASDAQ:COGT

    Does Cogent Biosciences, Inc. pay dividends?

    No, Cogent Biosciences, Inc. does not pay dividends

    What sector is Cogent Biosciences, Inc. in?

    Cogent Biosciences, Inc. is in the Healthcare sector

    What industry is Cogent Biosciences, Inc. in?

    Cogent Biosciences, Inc. is in the Biotechnology industry

    What country is Cogent Biosciences, Inc. based in?

    Cogent Biosciences, Inc. is headquartered in United States

    When did Cogent Biosciences, Inc. go public?

    Cogent Biosciences, Inc.'s initial public offering (IPO) was on March 29, 2018

    Is Cogent Biosciences, Inc. in the S&P 500?

    No, Cogent Biosciences, Inc. is not included in the S&P 500 index

    Is Cogent Biosciences, Inc. in the NASDAQ 100?

    No, Cogent Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Cogent Biosciences, Inc. in the Dow Jones?

    No, Cogent Biosciences, Inc. is not included in the Dow Jones index

    When was Cogent Biosciences, Inc.'s last earnings report?

    Cogent Biosciences, Inc.'s most recent earnings report was on May 6, 2025

    When does Cogent Biosciences, Inc. report earnings?

    The next expected earnings date for Cogent Biosciences, Inc. is August 6, 2025
    On this page